This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe
27 - 29 May, 2026
Congress CenterBasel Switzerland

Sophie Cullen
Principal Scientist at Promatix Biosciences
Speaker

Profile

As Principal Scientist for Promatix Biosciences, Sophie leads the Cell Biology group and is a project leader for a number of the pre-clinical programs. She has over 13 years of experience in drug discovery and platform development. She has previously held Senior and Lead Scientist positions across biotech and service organisations, including a number of start-ups. Sophie holds a BSc from University of Leicester and an MSc from Imperial College London.

Agenda Sessions

  • Hybrid Avidity-Gated EGFR x EphA2 Bispecific ADC Demonstrates Potent Anti-Tumour Efficacy while Sparing Keratinocytes

    16:15